VA HB1405 | 2020 | Regular Session

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 8 2020 - 25% progression, died in committee
Action: 2020-02-11 - Left in Health, Welfare and Institutions
Pending: House Health, Welfare and Institutions Committee
Text: Latest bill text (Prefiled) [HTML]

Summary

Price transparency for prescription drugs for the treatment Price transparency for prescription drugs for the treatment of diabetes; civil penalty. Requires a manufacturer of a prescription drug indicated for use in the treatment of diabetes to report certain information to the Commissioner of Health regarding the cost of such prescription drugs and to report additional information when the price of such a drug increases beyond the increase in the medical care component of the Consumer Price Index for the preceding year. The bill also requires pharmacy benefits managers to report information to the Commissioner of Health regarding any rebates negotiated with a manufacturer for such drugs. The bill provides that such information reported to the Commissioner of Health will be managed by the nonprofit organization that administers the Virginia All-Payer Claims Database. The bill provides that the Board of Health may assess a civil penalty of up to $1,000 per week per violation, not to exceed a total of $50,000 per violation, against a manufacturer or pharmacy benefits manager that fails, within the Board's determination, to make a good faith effort to meet a reporting deadline. In addition, the bill requires pharmacy benefits managers to register with the State Corporation Commission and authorizes the Commission to revoke the registration of any pharmacy benefits manager that fails to comply with reporting requirements specified in the bill. The Board of Pharmacy is authorized to revoke the permit or registration of any manufacturer that fails

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription drugs for the treatment of diabetes; price transparency, civil penalty.

Sponsors


Roll Calls

2020-02-03 - House - House: Subcommittee recommends striking from docket (6-Y 0-N) (Y: 6 N: 0 NV: 2 Abs: 0) [PASS]

History

DateChamberAction
2020-02-11HouseLeft in Health, Welfare and Institutions
2020-02-03HouseSubcommittee recommends striking from docket (6-Y 0-N)
2020-01-30HouseAssigned HWI sub: Health
2020-01-08HouseReferred to Committee on Health, Welfare and Institutions
2020-01-08HousePrefiled and ordered printed; offered 01/08/20 20100321D

Code Citations

ChapterArticleSectionCitation TypeStatute Text
321276.4(n/a)See Bill Text
321276.7:2(n/a)See Bill Text
3823465(n/a)See Bill Text
3823466(n/a)See Bill Text
3823467(n/a)See Bill Text
5413442.02(n/a)See Bill Text

Virginia State Sources


Bill Comments

feedback